Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Acta Angiologica
MENU
Shortcuts Submit an article Author Guidelines Ahead Of Print Publisher's Jubilee Conference Abstracts Reviewers 2022

open access

Vol 12, No 2 (2006)
Review paper
Published online: 2006-04-27
View PDF (Polish) Download PDF file
Get Citation

Therapeutic angiogenesis for critical limb ischemia

Mirosław Dziekiewicz, Emil Lisiak, Marek Maruszyński, Marek Janiak
Acta Angiologica 2006;12(2):43-50.

open access

Vol 12, No 2 (2006)
Review papers
Published online: 2006-04-27

Abstract

The use of angiogenic factors to effect therapeutic angiogenesis may be an attractive treatment modality for a substantial number of patients who have diffuse peripheral artery disease and who are not candidates for traditional revascularization procedures. Delivery of angiogenic factors as a protein or gene encoding for the respective protein product has been shown to induce angiogenesis in numerous animal models, and the expression of a functioning product has been demonstrated. Various early clinical trials of therapeutic angiogenesis have shown reduction in critical limb ischaemia (CLI) symptoms and increases in exercise time, as well as objective evidence of improved perfusion, and angiographic appearance following such angiogenic treatments. Initial phase I and II clinical trial results are encouraging and reflect the potential success of therapeutic angiogenesis as a clinical modality for the treatment of CLI. This review discusses the role of the most well-known growth factors under examination in therapeutic angiogenesis, along with the problems and considerations of this approach as a treatment strategy.

Abstract

The use of angiogenic factors to effect therapeutic angiogenesis may be an attractive treatment modality for a substantial number of patients who have diffuse peripheral artery disease and who are not candidates for traditional revascularization procedures. Delivery of angiogenic factors as a protein or gene encoding for the respective protein product has been shown to induce angiogenesis in numerous animal models, and the expression of a functioning product has been demonstrated. Various early clinical trials of therapeutic angiogenesis have shown reduction in critical limb ischaemia (CLI) symptoms and increases in exercise time, as well as objective evidence of improved perfusion, and angiographic appearance following such angiogenic treatments. Initial phase I and II clinical trial results are encouraging and reflect the potential success of therapeutic angiogenesis as a clinical modality for the treatment of CLI. This review discusses the role of the most well-known growth factors under examination in therapeutic angiogenesis, along with the problems and considerations of this approach as a treatment strategy.

Full Text:

View PDF (Polish) Download PDF file
Get Citation

Keywords

angiogenesis; critical limb ischaemia; growth factor

About this article
Title

Therapeutic angiogenesis for critical limb ischemia

Journal

Acta Angiologica

Issue

Vol 12, No 2 (2006)

Article type

Review paper

Pages

43-50

Published online

2006-04-27

Page views

713

Article views/downloads

1180

Bibliographic record

Acta Angiologica 2006;12(2):43-50.

Keywords

angiogenesis
critical limb ischaemia
growth factor

Authors

Mirosław Dziekiewicz
Emil Lisiak
Marek Maruszyński
Marek Janiak

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl